Re: "Treating Buccinator with Botulinum Toxin in Patients with Facial Synkinesis: A Previously Overlooked Target"

Ophthalmic Plastic and Reconstructive Surgery

Volumn 32, Issue 1, 2016, Pages 70-

  Chundury, Rao V ^b   Perry, Julian D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; NEUROTOXIN; BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

BUCCINATOR; FACE MUSCLE; FACIAL SYNKINESIS; HUMAN; LETTER; MOUTH CAVITY; MUSCLE CELL; PATHOLOGICAL REFLEX; PRIORITY JOURNAL; SMOOTH MUSCLE; SPEECH ARTICULATION; SYNKINESIS; FACE; FACIAL PARALYSIS;

BOTULINUM TOXINS; BOTULINUM TOXINS, TYPE A; FACE; FACIAL MUSCLES; FACIAL PARALYSIS; HUMANS; NEUROMUSCULAR AGENTS; SYNKINESIS;

EID: 84954443763     PISSN: 07409303     EISSN: 15372677     Source Type: Journal    
DOI: 10.1097/IOP.0000000000000608     Document Type: Letter

References (4)

1. Wei LA, Diels J, Lucarelli, M. Treating buccinator with botulinum toxin in patients with facial synkinesis: a previously overlooked target. Ophthal Plast Reconstr Surg 2015.
2. Kang HC, Kwak HH, Hu KS, et al. An anatomical study of the buccinator muscle fibres that extend to the terminal portion of the parotid duct, and their functional roles in salivary secretion. J Anat 2006;208:601-7.
3. Amano K Moriyama H, Shimada K, Matsumura G. Study of human adult parotid duct in the area of penetration through buccinator muscle and their functional relationship as a sphincter. Ital J Anat Embryol 2013;118:6-18.
4. Capaccio P, Torretta S, Ottavian F, Sambataro G, Pignataro L. Modern management of obstructive salivary diseases. Acta Otorhinolaryngol Ital 2007;27:161-172.